NH SPAC 2 (206640) - Total Liabilities

Latest as of December 2025: ₩37.46 Billion KRW ≈ $25.38 Million USD

Based on the latest financial reports, NH SPAC 2 (206640) has total liabilities worth ₩37.46 Billion KRW (≈ $25.38 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NH SPAC 2 long-term investment intensity to see how much of total assets are deployed in long-term investments.

NH SPAC 2 - Total Liabilities Trend (2015–2025)

This chart illustrates how NH SPAC 2's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of NH SPAC 2.

NH SPAC 2 Competitors by Total Liabilities

The table below lists competitors of NH SPAC 2 ranked by their total liabilities.

Company	Country	Total Liabilities
Daios Plastics S.A. AT:DAIOS	Greece	€107.87 Million
AirBoss of America Corp. TO:BOS	Canada	CA$171.05 Million
Muhak Co. Ltd KO:033920	Korea	₩105.07 Billion
Journey Medical Corp NASDAQ:DERM	USA	$62.74 Million
Diamond Building Products Public Company Limited BK:DRT	Thailand	฿1.67 Billion
Atrem S.A. WAR:ATR	Poland	zł152.29 Million
Tenaya Therapeutics Inc NASDAQ:TNYA	USA	$22.11 Million
SR Bancorp, Inc. Common stock NASDAQ:SRBK	USA	$959.00 Million

Liability Composition Analysis (2015–2025)

This chart breaks down NH SPAC 2's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 206640 equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.24	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.16	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.13	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NH SPAC 2's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NH SPAC 2 (2015–2025)

The table below shows the annual total liabilities of NH SPAC 2 from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩37.46 Billion ≈ $25.38 Million	+18.45%
2024-12-31	₩31.62 Billion ≈ $21.43 Million	+3.73%
2023-12-31	₩30.49 Billion ≈ $20.66 Million	-5.03%
2022-12-31	₩32.10 Billion ≈ $21.75 Million	-22.00%
2021-12-31	₩41.15 Billion ≈ $27.89 Million	-5.65%
2020-12-31	₩43.62 Billion ≈ $29.56 Million	+57.37%
2019-12-31	₩27.71 Billion ≈ $18.78 Million	-27.28%
2018-12-31	₩38.11 Billion ≈ $25.83 Million	-5.42%
2017-12-31	₩40.29 Billion ≈ $27.31 Million	+157.90%
2016-12-31	₩15.62 Billion ≈ $10.59 Million	+28.06%
2015-12-31	₩12.20 Billion ≈ $8.27 Million	--

About NH SPAC 2

KQ:206640 Korea Medical Devices

Market Cap

$136.73 Million

₩201.76 Billion KRW

Market Cap Rank

#18099 Global

#789 in Korea

Share Price

₩9410.00

Change (1 day)

-0.63%

52-Week Range

₩9410.00 - ₩14710.00

All Time High

₩36222.75